| Ident. | Authors (with country if any) | Title |
|---|
| 000062 (2020) |
Athimalaipet V. Ramanan [Royaume-Uni] ; Andrew D. Dick [Royaume-Uni] ; Catherine Guly [Royaume-Uni] ; Andrew Mckay [Royaume-Uni] ; Ashley P. Jones [Royaume-Uni] ; Ben Hardwick [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Matthew Smyth [Royaume-Uni] ; Thomas Jaki [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] | Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial |
| 000307 (2020) |
Ethan S. Sen [Royaume-Uni] ; A V Ramanan [Royaume-Uni] | Juvenile idiopathic arthritis-associated uveitis. |
| 000395 (2020) |
Mohsen Jari [Iran] ; Reza Shiari [Iran] ; Omid Salehpour [Iran] ; Khosro Rahmani [Iran] | Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis |
| 000448 (2020) |
Martina Bonacini [Italie] ; Alessandra Soriano [Italie] ; Luca Cimino [Italie] ; Luca De Simone [Italie] ; Elena Bolletta [Italie] ; Fabrizio Gozzi [Italie] ; Francesco Muratore [Italie] ; Maria Nicastro [Italie] ; Lucia Belloni [Italie] ; Alessandro Zerbini [Italie] ; Luigi Fontana [Italie] ; Carlo Salvarani [Italie] ; Stefania Croci [Italie] | Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases |
| 000517 (2020) |
Yael Sharon [États-Unis] ; David S. Chu [États-Unis] | Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis |
| 000660 (2019) |
A. Heiligenhaus [Allemagne] ; K. Minden [Allemagne] ; C. Tappeiner [Allemagne] ; H. Baus [Allemagne] ; B. Bertram [Allemagne] ; C. Deuter [Allemagne] ; I. Foeldvari [Allemagne] ; D. Föll [Allemagne] ; M. Frosch [Allemagne] ; G. Ganser [Allemagne] ; M. Gaubitz [Allemagne] ; A. Günther [Allemagne] ; C. Heinz [Allemagne] ; G. Horneff [Allemagne] ; C. Huemer [Allemagne] ; I. Kopp [Allemagne] ; C. Lommatzsch [Allemagne] ; T. Lutz [Allemagne] ; H. Michels [Allemagne] ; T. Ne [Allemagne] ; U. Neudorf [Allemagne] ; U. Pleyer [Allemagne] ; M. Schneider [Allemagne] ; H. Schulze-Koops [Allemagne] ; S. Thurau [Allemagne] ; M. Zierhut [Allemagne] ; H W Lehmann [Allemagne] | Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. |
| 000718 (2019) |
Valeria Dipasquale [Italie] ; Marco Atteritano [Italie] ; Jlenia Fresta [Italie] ; Irene Castagna [Italie] ; Giovanni Conti [Italie] | Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases. |
| 000743 (2019) |
Amruta Trivedi [Australie] ; Constance Katelaris [Australie] | The use of biologic agents in the management of uveitis. |
| 000786 (2019) |
F Nilüfer Yalç Nda [Turquie] ; Sirel Gür Güngör [Turquie] ; Mehmet Fatih Ka An De Irmenci [Turquie] ; Almila Sar Gül Sezenöz [Turquie] ; Zeynep Birsin Özçakar [Turquie] ; Esra Bask N [Turquie] ; Fatma Fato Yalç Nkaya [Turquie] ; Huban Atilla [Turquie] | The Clinical Characteristics of Pediatric Non-Infectious Uveitis in Two Tertiary Referral Centers in Turkey. |
| 000832 (2019) |
Alfredo Adán [Espagne] ; Aina Moll-Udina [Espagne] ; Julio Ramirez [Espagne] ; Victor Llorenç [Espagne] | Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report. |
| 000946 (2019) |
Ivan Foeldvari [Allemagne] ; Jens Klotsche [Allemagne] ; Gabriele Simonini [Italie] ; Clive Edelsten [Royaume-Uni] ; Sheila T. Angeles-Han [États-Unis] ; Regitze Bangsgaard [Danemark] ; Joke De Boer [Pays-Bas] ; Gabriele Brumm [Allemagne] ; Rosa Bou Torrent [Espagne] ; Tamas Constantin [Hongrie] ; Cinzia Delibero [Italie] ; Jesus Diaz [Espagne] ; Valeria Maria Gerloni [Italie] ; Margarida Guedes [Portugal] ; Arnd Heiligenhaus [Allemagne] ; Kaisu Kotaniemi [Finlande] ; Sanna Leinonen [Finlande] ; Kirsten Minden [Allemagne] ; Vasco Miranda [Portugal] ; Elisabetta Miserocchi [Italie] ; Susan Nielsen [Danemark] ; Martina Niewerth [Allemagne] ; Irene Pontikaki [Italie] ; Carmen Garcia De Vicuna [Espagne] ; Carla Zilhao [Portugal] ; Steven Yeh [États-Unis] ; Jordi Anton [Espagne] ; Joan Calzada [Espagne] | Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC) |
| 000A42 (2019) |
Chiharu Iwahashi [Japon] ; Hikari Ono [Japon] ; Mami Haruta [Japon] ; Takamasa Minami [Japon] ; Hisashi Mashimo [Japon] ; Hiroshi Shimojo [Japon] ; Nobuyuki Ohguro [Japon] | New onset or exacerbation of uveitis with infliximab: paradoxical effects? |
| 000A98 (2019) |
Horace Massa [Suisse] ; Spyros Y. Pipis [Royaume-Uni] ; Temilade Adewoyin [Royaume-Uni] ; Athanasios Vergados [Royaume-Uni] ; Sudeshna Patra [Royaume-Uni] ; Georgios D. Panos [Royaume-Uni] | Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges |
| 000B43 (2019) |
Kalpana Babu [Inde] ; Bhagya Sudheer [Inde] ; Anand P. Rao [Inde] | Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema – A case report |
| 000B56 (2019) |
Samendra Karkhur [États-Unis] ; Murat Hasanreisoglu [États-Unis, Turquie] ; Erin Vigil [États-Unis] ; Muhammad Sohail Halim [États-Unis] ; Muhammad Hassan [États-Unis] ; Carlos Plaza [États-Unis, Espagne] ; Nam V. Nguyen [États-Unis] ; Rubbia Afridi [États-Unis] ; Anh T. Tran [États-Unis] ; Diana V. Do [États-Unis] ; Yasir J. Sepah [États-Unis] ; Quan Dong Nguyen [États-Unis] | Interleukin-6 inhibition in the management of non-infectious uveitis and beyond |
| 000C84 (2019) |
Sara Touhami [France] ; Eléonore Diwo [France] ; Pascal Sève [France] ; Salim Trad [France] ; Philip Bielefeld [France] ; Damien Sène [France] ; Sebastien Abad [France] ; Antoine Brézin [France] ; Pierre Quartier [France] ; Isabelle Koné Paut [France] ; Michel Weber [France] ; Christophe Chiquet [France] ; Marie-Hélène Errera [France] ; Jérémie Sellam [France] ; Patrice Cacoub [France] ; Gilles Kaplanski [France] ; Laurent Kodjikian [France] ; Bahram Bodaghi [France] ; David Saadoun [France] | Expert opinion on the use of biological therapy in non-infectious uveitis. |
| 000D33 (2019) |
Virginia Miraldi Utz [États-Unis] ; Sabrina Bulas [États-Unis] ; Sarah Lopper [États-Unis] ; Matthew Fenchel [États-Unis] ; Ting Sa [États-Unis] ; Mitul Mehta [États-Unis] ; Daniel Ash [États-Unis] ; Daniel J. Lovell [États-Unis] ; Adam H. Kaufman [États-Unis] | Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis |
| 000D37 (2019) |
Muhammad Hassan [États-Unis] ; Nam V. Nguyen [États-Unis] ; Muhammad Sohail Halim [États-Unis] ; Rubbia Afridi [États-Unis] ; Mohammad Ali Sadiq [États-Unis] ; Samendra Karkhur [États-Unis] ; Erin Vigil [États-Unis] ; Selen Karabekirogullari [États-Unis] ; Quan Dong Nguyen [États-Unis] ; Diana V. Do [États-Unis] ; Yasir J. Sepah [États-Unis] | Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitis |
| 000D91 (2019) |
Greta Mastrangelo [Italie] ; Ivan Foeldvari ; Jordi Anton [Espagne] ; Gabriele Simonini [Italie] | Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? |
| 000E81 (2019) |
Guillaume Morelle [France] ; Julie Gueudry [France] ; Florence Uettwiller [France] ; Carine Wouters [France] ; Brigitte Bader-Meunier [France] ; Mathieu P. Robert [France] ; Dominique Monnet [France] ; Bahram Bodaghi [France] ; Martine Grall-Lerosey [France] ; Pierre Quartier [France] | Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort |
| 000F30 (2019) |
Akshay S. Thomas [États-Unis] | Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics. |
